Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
48.24
+0.38 (0.79%)
At close: May 15, 2025, 4:00 PM
49.23
+0.99 (2.05%)
After-hours: May 15, 2025, 5:55 PM EDT
Bio-Techne Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Bio-Techne stock ranges from a low of $60 to a high of $90. The average analyst price target of $73.44 forecasts a 52.24% increase in the stock price over the next year.
Price Target: $73.44 (+52.24%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bio-Techne stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 2 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 7 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $95 → $70 | Strong Buy | Maintains | $95 → $70 | +45.11% | May 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $72 → $63 | Hold | Maintains | $72 → $63 | +30.60% | May 8, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $95 → $75 | Strong Buy | Maintains | $95 → $75 | +55.47% | May 8, 2025 |
| Stifel | Stifel | Hold Maintains $75 → $60 | Hold | Maintains | $75 → $60 | +24.38% | May 8, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
Financial Forecast
Revenue This Year
1.25B
from 1.16B
Increased by 8.19%
Revenue Next Year
1.36B
from 1.25B
Increased by 8.61%
EPS This Year
1.95
from 1.05
Increased by 85.50%
EPS Next Year
2.24
from 1.95
Increased by 15.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.4B | 1.6B | ||
| Avg | 1.3B | 1.4B | 1.5B | ||
| Low | 1.2B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.4% | 14.8% | 19.1% | ||
| Avg | 8.2% | 8.6% | 11.2% | ||
| Low | 3.0% | 1.4% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.22 | 2.52 | 2.93 | ||
| Avg | 1.95 | 2.24 | 2.57 | ||
| Low | 1.82 | 1.91 | 2.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 111.0% | 29.4% | 30.8% | ||
| Avg | 85.5% | 15.0% | 14.8% | ||
| Low | 73.6% | -1.9% | -4.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.